Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Umesh Gowda

Family Medicine Rochester, MI Medical Doctor

NPI 1033141783 CMS profile 183448

1101 W University Dr, Rochester, MI 48307

Open in the dashboard

General payments

$9,117

40 records reported · program years 2019–2025

Research payments

$50

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$238,726 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Umesh Gowda of Rochester, MI is reported in the CMS Open Payments database as having received $9,117 across 40 general payments and $50 in research payments paid to them. Separately, studies naming them as principal investigator received $238,726 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Family Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,600 2
2024 General $4,640 4
2023 General $25 1
2022 General $110 1
2022 Research $50 1
2021 General $66 1
2020 General $428 23
2019 General $249 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Umesh Gowda
  • Family Medicine median
  • Middle half of Family Medicine
  • National median

In program year 2025, general payments to Umesh Gowda were reported at $3,600. Among 56,786 Family Medicine profiles paid that year, the median was $155 and the middle half received between $45 and $549.

Show as a table
Year Umesh Gowda Family Medicine median Middle half National median
2019 $249 $150 $41–$543 $163
2020 $428 $120 $32–$415 $114
2021 $66 $137 $35–$551 $132
2022 $110 $137 $37–$512 $149
2023 $25 $149 $42–$545 $160
2024 $4,640 $156 $44–$560 $164
2025 $3,600 $155 $45–$549 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $7,920 4 payments
  2. Boston Scientific Corporation $378 12 payments
  3. Medtronic Vascular, Inc. $243 19 payments
  4. Medical Device Business Services, Inc. $180 1 payment
  5. Biosense Webster, Inc. $141 1 payment
  6. Insmed, Inc. $121 1 payment
  7. Shionogi Inc $110 1 payment
  8. Bard Peripheral Vascular, Inc. $25 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $7,920 4 payments
  2. Food and Beverage $1,018 35 payments
  3. Travel and Lodging $180 1 payment
Products named General payments · program years 2019–2025
  1. Diamondback Coronary $7,920 4 payments
  2. WATCHMAN Structural Heart $292 9 payments
  3. CoreValve Evolut $180 12 payments
  4. Carto 3 $180 1 payment
  5. NUVISION ICE CATHETER $141 1 payment
  6. Arikayce $121 1 payment
  7. Fetroja $110 1 payment
  8. WATCHMAN Pain Management $66 1 payment
  9. Resolute $49 6 payments
  10. RotarexS 6 F x 135 cm $25 1 payment
  11. Other $33 3 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Novo Nordisk Inc $50 1 payment

Records

41 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record